{"paper_id":"ce9d68aa-a876-4b1a-b1c4-13dedc57d9b9","body_text":"Abstract\nFibrosis remains incompletely understood, particularly in terms of how immune mediators shape stromal programs. We used a spontaneous large‑animal model—endometrosis (equine endometrial fibrosis) to define how interleukin‑4 (IL‑4) reprograms fibroblasts from healthy and fibrotic endometrium. Primary fibroblasts were exposed to IL‑4 (10 ng/mL) for 48 or 96 h. At 48 h, bulk transcriptomes revealed 1307 differentially expressed genes (DEGs; 648 up, 659 down) and 1271 DEGs (645 up, 626 down) in fibroblasts derived from endometria without or with endometrosis, respectively. Enrichment analyses implicated cellular metabolism, extracellular matrix (ECM) organization and remodeling, and signaling pathways commonly linked to fibrogenesis. IL‑4 also affected the long non‑coding RNA (lncRNA) expression, with 143 and 135 differentially expressed lncRNAs in fibroblasts derived from healthy or fibrotic endometria, respectively; linking these lncRNAs to DEGs involved in inflammation, ECM organization, and cytokine signaling. Moreover, IL‑4 increased proliferation and viability in fibroblasts derived from healthy or fibrotic endometria, while selectively reducing migration in fibroblasts derived from endometria without fibrosis after 96 h. IL‑4 further altered mRNA expression, protein abundance, and gelatinolytic activity of matrix metalloproteinases in a manner contingent on the fibrosis status of the tissue of origin, indicating stage‑dependent control of ECM turnover. Collectively, these data identify IL‑4 as a potent modulator of fibroblast function in a spontaneous large‑animal fibrosis model, revealing fibrosis stage‑dependent responses.\nGraphical Abstract\nInterleukin-4 (IL-4) modulates the transcriptome, extracellular matrix (ECM)–associated components, and functional characteristics of mare endometrial fibroblasts derived from healthy and fibrotic uteri. IL-4 treatment induces distinct transcriptomic and proteomic changes, alters cell proliferation, migration, collagen contractility, and MMP activity, and elicits differential responses between non-fibrotic and fibrotic cells, highlighting fibrosis-dependent effects of IL-4 on endometrial remodeling.\nSimilar content being viewed by others\nData availability\nThe raw reads have been deposited in the Sequence Read Archive (SRA) under accession number PRJNA1154451.\nReferences\nAllen JE (2023) IL-4 and IL-13: regulators and effectors of wound repair. Annu Rev Immunol 41:229–254\nAndersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250\nAoudjehane L, Pissaia AJ, Scatton O, Podevin P, Massault PP, Chouzenoux S, Soubrane O, Calmus Y, Conti F (2008) Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway. Lab Invest 88:973–985\nArpino V, Brock M, Gill SE (2015) The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol 44–46:247–254\nArthur MJ, Iredale JP, Mann DA (1999) Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 23:940–943\nBarron L, Wynn TA (2011) Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol 300:G723–G728\nBatsaikhan B, Lu MY, Yeh ML, Huang CI, Huang CF, Lin ZY, Chen SC, Huang JF, Hsieh PH, Chuang WL, Lee JC, Yu ML, Dai CY (2019) Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C. J Chin Med Assoc 82:277–281\nBhattacharya M, Ramachandran P (2023) Immunology of human fibrosis. Nat Immunol 24:1423–1433\nBracher V, Mathias S, Allen WR (1996) Influence of chronic degenerative endometritis (endometrosis) on placental development in the mare. Equine Vet J 28:180–188\nBukowska J, Kopcewicz M, Kur-Piotrowska A, Szostek-Mioduchowska AZ, Walendzik K, Gawronska-Kozak B (2018) Effect of TGFbeta1, TGFbeta3 and keratinocyte conditioned media on functional characteristics of dermal fibroblasts derived from reparative (Balb/c) and regenerative (Foxn1 deficient; nude) mouse models. Cell Tissue Res 374:149–163\nCamacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL (2009) BLAST+: architecture and applications. BMC Bioinformatics 10:421\nCui X, Shi E, Li J, Li Y, Qiao Z, Wang Z, Liu M, Tang W, Sun Y, Zhang Y, Xie Y, Zhen J, Wang X, Yi F (2022) GPR87 promotes renal tubulointerstitial fibrosis by accelerating glycolysis and mitochondrial injury. Free Radic Biol Med 189:58–70\nD’Arcy Q, Gharaee-Kermani M, Zhilin-Roth A, Macoska JA (2022) The IL-4/IL-13 signaling axis promotes prostatic fibrosis. PLoS One 17:e0275064\nDobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21\nDoucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B (1998) IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 10:1421–1433\nFlores JM, Rodriguez A, Sanchez J, Gomezcuetara C, Ramiro F (1995) Endometriosis in mares - incidence of histopathological alterations. Reprod Domest Anim 30:61–65\nGiannandrea M, Parks WC (2014) Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech 7:193–203\nGomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111–122\nGu Z (2022) Complex heatmap visualization. Imeta 1:e43\nHan S, Liang Y, Ma Q, Xu Y, Zhang Y, Du W, Wang C, Li Y (2019) Lncfinder: an integrated platform for long non-coding RNA identification utilizing sequence intrinsic composition, structural information and physicochemical property. Brief Bioinform 20:2009–2027\nHenderson J, O’Reilly S (2021) The emerging role of metabolism in fibrosis. Trends Endocrinol Metab 32:639–653\nHenderson NC, Rieder F, Wynn TA (2020) Fibrosis: from mechanisms to medicines. Nature 587:555–566\nHofacker IL, Fontana W, Stadler PF, Bonhoeffer LS, Tacker M, Schuster P (1994) Fast folding and comparison of RNA secondary structures. Monatsh Chem 125:167–188\nHoffmann C, Ellenberger C, Mattos RC, Aupperle H, Dhein S, Stief B, Schoon HA (2009) The equine endometrosis: new insights into the pathogenesis. Anim Reprod Sci 111:261–278\nHong KH, Cho ML, Min SY, Shin YJ, Yoo SA, Choi JJ, Kim WU, Song SW, Cho CS (2007) Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin Exp Immunol 147:573–579\nHuaux F, Liu T, McGarry B, Ullenbruch M, Phan SH (2003) Dual roles of IL-4 in lung injury and fibrosis. J Immunol 170:2083–2092\nHwang S, Chung KW (2021) Targeting fatty acid metabolism for fibrotic disorders. Arch Pharm Res 44:839–856\nKenney RM, Doig PA (1986) Equine endometrial biopsy. In: Morrow DA (ed) Current therapy in theriogenology, pp 723–29\nKotlowska M, Kowalski R, Glogowski J, Jankowski J, Ciereszko A (2005) Gelatinases and serine proteinase inhibitors of seminal plasma and the reproductive tract of turkey (Meleagris gallopavo). Theriogenology 63:1667–1681\nLehmann J, Ellenberger C, Hoffmann C, Bazer FW, Klug J, Allen WR, Sieme H, Schoon HA (2011) Morpho-functional studies regarding the fertility prognosis of mares suffering from equine endometrosis. Theriogenology 76:1326–1336\nLiu X, Conner H, Kobayashi T, Abe S, Fang Q, Wen FQ, Rennard SI (2003) Synergetic effect of interleukin-4 and transforming growth factor-beta1 on type I collagen gel contraction and degradation by HFL-1 cells: implication in tissue remodeling. Chest 123:427S-S428\nLorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6:26\nLove MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550\nLupher ML Jr., Gallatin WM (2006) Regulation of fibrosis by the immune system. Adv Immunol 89:245–288\nMiki H, Manresa MC (2023) Novel fibroblast phenotypes in homeostasis and chronic inflammation: from functions to potential regulators. J Physiol 601:2273–2291\nPadmanabhan J, Maan ZN, Kwon SH, Kosaraju R, Bonham CA, Gurtner GC (2019) In vivo models for the study of fibrosis. Adv Wound Care 8:645–654\nPeng H, Sarwar Z, Yang XP, Peterson EL, Xu J, Janic B, Rhaleb N, Carretero OA, Rhaleb NE (2015) Profibrotic role for interleukin-4 in cardiac remodeling and dysfunction. Hypertension 66:582–589\nPertea G, Pertea M (2020) GFF utilities: GffRead and GffCompare. F1000Res. https://doi.org/10.12688/f1000research.23297.2\nPertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL (2015) StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33:290–295\nRabbani N, Thornalley PJ (2019) Hexokinase-2 glycolytic overload in diabetes and ischemia-reperfusion injury. Trends Endocrinol Metab 30:419–431\nRosenbloom J, Macarak E, Piera-Velazquez S, Jimenez SA (2017) Human fibrotic diseases: current challenges in fibrosis research. Methods Mol Biol 1627:1–23\nSempowski GD, Beckmann MP, Derdak S, Phipps RP (1994) Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 152:3606–3614\nSmolgovsky S, Theall B, Wagner N, Alcaide P (2024) Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis. Am J Physiol Heart Circ Physiol 326:H303–H316\nSteinke JW, Crouse CD, Bradley D, Hise K, Lynch K, Kountakis SE, Borish L (2004) Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 30:212–219\nSzóstek-Mioduchowska A, Wójtowicz A, Sadowska A, Moza Jalali B, Slyszewska M, Lukasik K, Gurgul A, Szmatola T, Bugno-Poniewierska M, Ferreira-Dias G, Skarzynski DJ (2023) Transcriptomic profiling of mare endometrium at different stages of endometrosis. Sci Rep 13:16263\nTian Y, Duan C, Feng J, Liao J, Yang Y, Sun W (2023) Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: a review. Int J Biochem Cell Biol 155:106361\nUng CY, Onoufriadis A, Parsons M, McGrath JA, Shaw TJ (2021) Metabolic perturbations in fibrosis disease. Int J Biochem Cell Biol 139:106073\nWang S, Liang Y, Dai C (2022) Metabolic regulation of fibroblast activation and proliferation during organ fibrosis. Kidney Dis (Basel) 8:115–125\nWen FQ, Kohyama T, Liu X, Zhu YK, Wang H, Kim HJ, Kobayashi T, Abe S, Spurzem JR, Rennard SI (2002) Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol 26:484–490\nWickham H (2016) Data analysis. In Hadley Wickham (ed.), ggplot2: Elegant Graphics for Data Analysis (Springer International Publishing: Cham)\nWillems M, Olsen C, Caljon B, Vloeberghs V, De Schepper J, Tournaye H, Van Saen D, Goossens E (2022) Transcriptomic differences between fibrotic and non-fibrotic testicular tissue reveal possible key players in Klinefelter syndrome-related testicular fibrosis. Sci Rep 12:21518\nWitkowski M, Duliban M, Rak A, Profaska-Szymik M, Gurgul A, Arent ZJ, Galuszka A, Kotula-Balak M (2022) Next-generation sequencing analysis discloses genes implicated in equine endometrosis that may lead to tumorigenesis. Theriogenology 189:158–166\nWu YS, Liang S, Li DY, Wen JH, Tang JX, Liu HF (2021) Cell cycle dysregulation and renal fibrosis. Front Cell Dev Biol 9:714320\nWynn TA (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4:583–594\nWynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18:1028–1040\nYin X, Choudhury M, Kang JH, Schaefbauer KJ, Jung MY, Andrianifahanana M, Hernandez DM, Leof EB (2019) Hexokinase 2 couples glycolysis with the profi brotic actions of TGF-beta. Sci Signal 12:eaax4067\nYu G, Wang LG, Han Y, He QY (2012) Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS 16:284–287\nZhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, Racanelli AC, Zhang L, Ye T, Ding B, Zhang B, Yang J, Yao Y (2022) Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther 7:206\nZhao S, Fernald RD (2005) Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 12:1047–64\nAcknowledgements\nThe authors would like to thank Agnieszka Bacławska, Witold Krzywiec, Ewa Liszewska, and Krzysztof Witek from the Institute of Animal Reproduction and Food Research, PAS, Olsztyn, for their technical support. Graphical abstract was created using images from Servier Medical Art (https://smart.servier.com), licensed under a Creative Commons Attribution 3.0 Unported License (CC BY 3.0).\nFunding\nThis study was carried out as a part of the Sonata project (2019/35/D/NZ9/02989), financed by the National Science Centre, Poland.\nAuthor information\nAuthors and Affiliations\nContributions\nA.W.—writing original draft, study design, methodology, formal analysis, visualization, investigation, statistical analysis; A.S—investigation; K.M.—bioinformatic analysis of NGS results, visualization; T.M.—bioinformatic analysis of NGS results, visualization; M.M.K.—formal analysis; A.S.-M.—conceptualization, study design, funding acquisition, methodology, formal analysis, editing original draft.\nCorresponding author\nEthics declarations\nEthics approval\nThis study used mare endometrial tissue obtained post-mortem from mares at a commercial slaughterhouse, where the animals were processed solely for meat production. As the samples were collected after death from non-experimental animals, no ethical approval was required.\nCompeting interests\nThe authors declare no competing interests.\nAdditional information\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nSupplementary Information\nBelow is the link to the electronic supplementary material.\nESM 1 (download DOCX )\n(5.25 MB DOCX)\nESM 2 (download XLSX )\n(765 KB XLSX)\nRights and permissions\nSpringer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.\nAbout this article\nCite this article\nWójtowicz , A., Sadowska, A., Myszczyński, K. et al. Interleukin-4 changes the transcriptome, ECM-associated components and function of mare endometrial fibroblast: Insights from healthy and fibrotic cells. Cell Tissue Res 403, 25 (2026). https://doi.org/10.1007/s00441-026-04049-6\nReceived:\nAccepted:\nPublished:\nVersion of record:\nDOI: https://doi.org/10.1007/s00441-026-04049-6","source_license":"CC0","license_restricted":false}